Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 5,418 shares at $74.00 ($401K) on 2025-11-25, disclosed to the SEC on 2025-11-26.
Scheduled sale ($401k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVMD | SELL | 2026-06-18 | $425K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |